Q4 2024 Ultralife Corp Earnings Call Transcript
Key Points
- Ultralife Corp (ULBI) reported Q4 sales of $43.9 million and an operating income of $1.5 million, despite incurring $1.1 million in one-time costs related to the Electrochem acquisition.
- The acquisition of Electrochem Solutions is expected to provide vertical integration capabilities, expand market opportunities, and create cost synergies with existing lithium cell businesses.
- The company has successfully negotiated long-term supply agreements, enhancing supply chain efficiency and cost leverage.
- Ultralife Corp (ULBI) has completed several lean productivity projects, resulting in at least 30% greater throughput and efficiency.
- The company has a strong backlog of $102.2 million, representing 62% of trailing twelve-month sales, indicating a healthy demand pipeline.
- Revenues from the Communications Systems segment declined by 55.1% year-over-year, primarily due to delayed shipments and timing of orders.
- The company reported a decrease in consolidated gross margin to 24.2%, down from 25.6% in the previous year, due to lower medical battery sales and factory cost absorption.
- Operating expenses increased by 17.7% year-over-year, partly due to one-time acquisition costs and the inclusion of Electrochem.
- Ultralife Corp (ULBI) identified a material weakness in its internal control process, necessitating the hiring of additional qualified accounting personnel.
- The company is facing legal challenges related to a business interruption claim from a 2023 cyberattack, which has not been fully settled with the insurance underwriter.
Good day, and thank you for standing by. Welcome to the Ultralife Corporation fourth quarter 2024 results. At this time, all participants are in a listen-only mode. After the speakers' presentation, there'll be a question-and-answer session. (Operator Instructions) Please be advised today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Alex Villalta. Please go ahead.
Thank you, Kevin, and good morning, everyone, and thank you for joining us this morning for Ultralife Corporation's earnings conference call for the fourth quarter of fiscal 2024. With us on today's call are Mike Manna, Ultralife's President and CEO; and Phil Fain, Ultralife's Chief Financial Officer. The earnings press release was issued earlier this morning, and if anyone has not yet received a copy, I invite you to visit the company's website, ultralife.com, where you will find the release under Investor News in the Investor Relations section.
Before turning the call over to management, I'd
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
